Moloney Securities Asset Management, LLC Northwest Biotherapeutics Inc Transaction History
Moloney Securities Asset Management, LLC
- $787 Million
- Q3 2025
A detailed history of Moloney Securities Asset Management, LLC transactions in Northwest Biotherapeutics Inc stock. As of the latest transaction made, Moloney Securities Asset Management, LLC holds 534,710 shares of NWBO stock, worth $128,330. This represents 0.02% of its overall portfolio holdings.
Number of Shares
534,710
Previous 501,560
6.61%
Holding current value
$128,330
Previous $120,000
6.67%
% of portfolio
0.02%
Previous 0.02%
Shares
23 transactions
Others Institutions Holding NWBO
# of Institutions
12Shares Held
765KCall Options Held
0Put Options Held
0-
Vsm Wealth Advisory, LLC Hunt Valley, MD65.6KShares$15,7370.0% of portfolio
-
Opus Capital Group, LLC60.2KShares$14,4360.0% of portfolio
-
Williams Jones Wealth Management, Llc. New York, NY27KShares$6,4800.0% of portfolio
-
Ethos Financial Group, LLC King Of Prussia, PA25.4KShares$6,0840.0% of portfolio
-
Alpha Mark Advisors, LLC Ft. Wright, KY14KShares$3,3610.0% of portfolio
About NORTHWEST BIOTHERAPEUTICS INC
- Ticker NWBO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,037,230,016
- Market Cap $249M
- Description
- Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, wh...